Anita Courcoulas, MD; R. Yates Coley, PhD; Jeanne M. Clark, MD; et al.
open access
has audio
JAMA Surg. 2020;155(3):194-204. doi:10.1001/jamasurg.2019.5470
This large cohort study uses data from the US National Patient-Centered Clinical Research Network to assess for up to 5 years risks of intervention, operation, endoscopy, hospitalization, and mortality associated with Roux-en-Y gastric bypass or sleeve gastrectomy.
-
Podcast:
Interventions and Operations 5 Years After Bariatric Surgery
-
Invited Commentary
Bariatric Surgery Is Safe and It Works
Anne P. Ehlers, MD, MPH; Amir A. Ghaferi, MD, MS
JAMA Surg
Joyce V. Veld, MD, MSc; Femke J. Amelung, MD, PhD; Wernard A. A. Borstlap, MD, PhD; et al.
free access
JAMA Surg. 2020;155(3):206-215. doi:10.1001/jamasurg.2019.5466
This cohort study compares decompressing stoma vs self-expandable metal stent as a bridge to surgery for nonlocally advanced left-sided obstructive colon cancer using propensity score matching.
Katherine C. Lee, MD, MSc; Daniel Sturgeon, MS; Stuart Lipsitz, ScD; et al.
free access
JAMA Surg. 2020;155(3):216-223. doi:10.1001/jamasurg.2019.5087
This cohort study examines whether Medicare beneficiaries who undergo emergency general surgery experience similar 1-year outcomes compared with patients admitted with acute medical conditions.
Dirk Stengel, MD, PhD, MSc; Sven Mutze, MD, PhD; Claas Güthoff, PhD; et al.
open access
JAMA Surg. 2020;155(3):224-232. doi:10.1001/jamasurg.2019.5468
This time-series cohort study assesses whether low-dose whole-body computed tomography increases the rate of missed injury diagnoses at the point of care compared with the standard dose among patients with multiple trauma.
Francesco Carli, MD, MPhil; Guillaume Bousquet-Dion, MD; Rashami Awasthi, MSc; et al.
free access
JAMA Surg. 2020;155(3):233-242. doi:10.1001/jamasurg.2019.5474
This randomized clinical trial assesses the extent to which a prehabilitation program vs postoperative rehabilitation affects 30-day postoperative complications in frail patients undergoing colorectal cancer resection.
Mehra Golshan, MD, MBA; Sibylle Loibl, MD; Stephanie M. Wong, MD; et al.
free access
online only
JAMA Surg. 2020;155(3):e195410. doi:10.1001/jamasurg.2019.5410
This phase 3 randomized clinical trial assesses the role of neoadjuvant systemic therapy in conversion from ineligibility to eligibility for breast-conserving therapy and to assess the association of response to therapy, germline BRCA status, and region of treatment with surgical choice in women with triple-negative breast cancer.
Allan B. Massie, PhD, MHS; Courtenay M. Holscher, MD; Macey L. Henderson, PhD; et al.
free access
online only
JAMA Surg. 2020;155(3):e195472. doi:10.1001/jamasurg.2019.5472
This secondary analysis of a cohort study aims to determine the association between renal function in the first 6 months postdonation and subsequent risk of end-stage renal disease in kidney donors.
-
Invited Commentary
End-stage Renal Disease After Kidney Donation鈥擬ore Research Needed
Arthur J. Matas, MD; Hassan N. Ibrahim, MD; David M. Vock, PhD
JAMA Surg